These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

683 related articles for article (PubMed ID: 10362442)

  • 1. Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs.
    Hirschfeld RM
    J Clin Psychiatry; 1999 May; 60(5):326-35. PubMed ID: 10362442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs.
    Doyle JJ; Casciano J; Arikian S; Tarride JE; Gonzalez MA; Casciano R
    Value Health; 2001; 4(1):16-31. PubMed ID: 11704969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of severe depression: is there an efficacy gap between SSRI and TCA antidepressant generations?
    Nierenberg AA
    J Clin Psychiatry; 1994 Sep; 55 Suppl A():55-9; discussion 60-1, 98-100. PubMed ID: 7961543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant effectiveness in severe depression and melancholia.
    Schatzberg AF
    J Clin Psychiatry; 1999; 60 Suppl 4():14-21; discussion 22. PubMed ID: 10086479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: a meta-analysis of randomized controlled trials.
    Einarson TR; Arikian SR; Casciano J; Doyle JJ
    Clin Ther; 1999 Feb; 21(2):296-308. PubMed ID: 10211533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine versus other types of pharmacotherapy for depression.
    Magni LR; Purgato M; Gastaldon C; Papola D; Furukawa TA; Cipriani A; Barbui C
    Cochrane Database Syst Rev; 2013 Jul; (7):CD004185. PubMed ID: 24353997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the comparative effectiveness of antidepressant therapies: a prospective clinical practice study.
    Parker G; Roy K; Wilhelm K; Mitchell P
    J Clin Psychiatry; 2001 Feb; 62(2):117-25. PubMed ID: 11247097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.
    Bauer M; Tharmanathan P; Volz HP; Moeller HJ; Freemantle N
    Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):172-85. PubMed ID: 19165525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants.
    Perry PJ
    J Affect Disord; 1996 Jun; 39(1):1-6. PubMed ID: 8835647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe depression: is there a best approach?
    Sonawalla SB; Fava M
    CNS Drugs; 2001; 15(10):765-76. PubMed ID: 11602003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of the clinical efficacy of mirtazapine.
    Benkert O; Muller M; Szegedi A
    Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S23-6. PubMed ID: 12404666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo.
    Mallick R; Chen J; Entsuah AR; Schatzberg AF
    J Clin Psychiatry; 2003 Mar; 64(3):321-30. PubMed ID: 12716275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability.
    Anderson IM
    Depress Anxiety; 1998; 7 Suppl 1():11-7. PubMed ID: 9597346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of antidepressants currently used to treat anxiety disorders.
    Feighner JP
    J Clin Psychiatry; 1999; 60 Suppl 22():18-22. PubMed ID: 10634351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine versus other types of pharmacotherapy for depression.
    Cipriani A; Brambilla P; Furukawa T; Geddes J; Gregis M; Hotopf M; Malvini L; Barbui C
    Cochrane Database Syst Rev; 2005 Oct; (4):CD004185. PubMed ID: 16235353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.
    Guelfi JD; Ansseau M; Timmerman L; Kørsgaard S;
    J Clin Psychopharmacol; 2001 Aug; 21(4):425-31. PubMed ID: 11476127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A quantitative review on outcome-to-antidepressants in melancholic unipolar depression.
    Valerio MP; Szmulewicz AG; Martino DJ
    Psychiatry Res; 2018 Jul; 265():100-110. PubMed ID: 29702301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of depression in the elderly: a review of the recent literature on the efficacy of single- versus dual-action antidepressants.
    Mukai Y; Tampi RR
    Clin Ther; 2009 May; 31(5):945-61. PubMed ID: 19539096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analytical studies on new antidepressants.
    Anderson IM
    Br Med Bull; 2001; 57():161-78. PubMed ID: 11719915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression.
    Stahl SM; Entsuah R; Rudolph RL
    Biol Psychiatry; 2002 Dec; 52(12):1166-74. PubMed ID: 12488062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.